Oura Raises $900M in Series E Funding, Catapulting Smart Ring Sales and Valuation
Oura, the company behind the popular health-tracking Oura ring, has secured a staggering $900 million in Series E funding, propelling its valuation to $11 billion. This substantial investment comes on the heels of exponential growth in sales and revenue, solidifying Oura's position as a leader in the wearable health technology market.
Record-Breaking Sales and Revenue
Oura's smart ring has experienced a surge in popularity, with the company reporting sales of 5.5 million rings since its launch in 2015. Remarkably, nearly 3 million of these sales occurred in 2025 alone, contributing to an expected total revenue of $1 billion for the year from device sales and app subscriptions combined.
This meteoric rise represents a doubling of Oura's revenue from the previous year when it reported $500 million in earnings. The company's CEO, Tom Hale, had previously indicated that Oura was already profitable, making this latest financial milestone even more impressive.
Funding Details and Future Plans
The Series E funding round was spearheaded by Fidelity Management & Research Company, with significant contributions from new investor ICONIQ, as well as Whale Rock and Atreides. This latest investment has more than doubled Oura's valuation since its Series D raise in December 2024, when the company was valued at $5.2 billion.
Oura plans to allocate the newly acquired funds towards several key areas:
- Further development of AI integration in its products
- Expansion of global distribution networks
- Development of new health features for the Oura ring and app
Shifting Landscape in Digital Health
Oura's success comes at a time when digital health tools are gaining increased attention from both consumers and policymakers. The company's growth aligns with a broader trend in the healthcare industry, as evidenced by recent statements from Health Secretary Robert F. Kennedy Jr., who suggested the possibility of providing wearables to all Medicare beneficiaries.
In response to this evolving landscape, Oura has been actively developing relationships with health plans and exploring the connection between sleep habits and chronic diseases. This strategic move positions the company to transition from a consumer wellness product to a more integral part of the healthcare ecosystem.
Tom Hale, Oura's CEO, emphasized the company's vision, stating, "We're proud to be building not just a product, but a global movement toward proactive health—helping people understand their bodies, make better lifestyle decisions, and connect more effectively with their healthcare providers."
As Oura continues to expand its reach and capabilities, the company is poised to play a significant role in shaping the future of preventive health and wearable technology.
References
- Oura raises $900M series E as smart ring sales catapult company's growth
Since it started selling the Oura ring in 2015, the smart ring maker has sold 5.5 million rings. Three million have been in the last year alone.
Explore Further
What is the competitive landscape for wearable health technology, and who are Oura's main competitors in this space?
How does Oura plan to integrate AI into its products, and what specific improvements or features are expected?
What partnerships or collaborations are Oura pursuing with healthcare providers and health plans to further integrate into the healthcare ecosystem?
How does Oura intend to expand its global distribution networks, and which key markets are they targeting for growth?
What potential impact could initiatives like providing wearables to Medicare beneficiaries have on the adoption and scalability of Oura's smart rings in the healthcare industry?